• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢肿瘤中11号染色体等位基因失衡及其与临床病理的相关性

Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

作者信息

Gabra H, Taylor L, Cohen B B, Lessels A, Eccles D M, Leonard R C, Smyth J F, Steel C M

机构信息

ICRF Medical Oncology Unit, Western General Hospital, Edinburgh, UK.

出版信息

Br J Cancer. 1995 Aug;72(2):367-75. doi: 10.1038/bjc.1995.340.

DOI:10.1038/bjc.1995.340
PMID:7640220
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2033969/
Abstract

Allele imbalance on chromosome 11 loci in ovarian cancer is a frequent event, suggesting the presence of tumour-suppressor genes for ovarian carcinogenesis on this chromosome. Ten highly polymorphic (CA) repeat microsatellites were used to determine allele imbalance in 60 primary ovarian tumours, including 47 epithelial ovarian cancers (EOCs). Forty EOCs (85%) showed allele imbalance at one or more loci, and in 39 of these (83%) the data suggested subchromosomal deletions: eight of 11p only; six of 11q only; and 25 of both 11p and 11q. Three consensus regions of deletion were indicated at 11p15.5-p15.3, 11q12-q22 and 11q23.3-q24.1. Allele imbalance at the 11q subtelomeric region (D11S912) correlated significantly with adverse survival, while imbalance at 11q14.3 and retention of heterozygosity at 11q22 (close to the site of the progesterone receptor gene) were associated with favourable clinicopathological features. The findings allow development of a preliminary model for the molecular evolution of epithelial ovarian cancer.

摘要

卵巢癌中11号染色体位点的等位基因失衡是常见现象,提示该染色体上存在参与卵巢癌发生的肿瘤抑制基因。使用10个高度多态性的(CA)重复微卫星来确定60例原发性卵巢肿瘤中的等位基因失衡情况,其中包括47例上皮性卵巢癌(EOC)。40例EOC(85%)在一个或多个位点显示等位基因失衡,其中39例(83%)的数据提示存在亚染色体缺失:仅11p有8例;仅11q有6例;11p和11q均有25例。在11p15.5 - p15.3、11q12 - q22和11q23.3 - q24.1处显示出三个缺失的共识区域。11q亚端粒区域(D11S912)的等位基因失衡与不良生存显著相关,而11q14.3处的失衡以及11q22(靠近孕激素受体基因位点)的杂合性保留与良好的临床病理特征相关。这些发现有助于建立上皮性卵巢癌分子进化的初步模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed00/2033969/52d00b89c6f9/brjcancer00042-0117-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed00/2033969/52d00b89c6f9/brjcancer00042-0117-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed00/2033969/52d00b89c6f9/brjcancer00042-0117-a.jpg

相似文献

1
Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.卵巢肿瘤中11号染色体等位基因失衡及其与临床病理的相关性
Br J Cancer. 1995 Aug;72(2):367-75. doi: 10.1038/bjc.1995.340.
2
Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.人类卵巢癌中11号染色体短臂上的结构杂合性缺失。与分化程度呈正相关。
Cancer. 1993 Oct 15;72(8):2423-32. doi: 10.1002/1097-0142(19931015)72:8<2423::aid-cncr2820720821>3.0.co;2-p.
3
Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer.卵巢癌中11号染色体q区域杂合性缺失的两个区域的细化
Cancer Res. 1996 Feb 15;56(4):741-4.
4
Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21.卵巢癌中5号染色体长臂杂合性缺失常伴有TP53突变,并确定了5q13.1-21处的一个肿瘤抑制基因位点。
Br J Cancer. 1996 Jul;74(1):115-9. doi: 10.1038/bjc.1996.324.
5
Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.胃腺癌中11号染色体杂合性缺失
Cancer Res. 1996 Jan 15;56(2):268-72.
6
Polymerase chain reaction allelotyping of human ovarian cancer.人类卵巢癌的聚合酶链反应基因分型
Br J Cancer. 1994 Mar;69(3):429-38. doi: 10.1038/bjc.1994.79.
7
Molecular genetic changes associated with ovarian cancer.与卵巢癌相关的分子遗传学改变。
Gynecol Oncol. 1994 Nov;55(2):245-52. doi: 10.1006/gyno.1994.1285.
8
Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer.人类前列腺癌中11号染色体p15、p12、q22、q23 - 24位点的缺失
Int J Cancer. 1997 Jul 17;72(2):283-8. doi: 10.1002/(sici)1097-0215(19970717)72:2<283::aid-ijc14>3.0.co;2-h.
9
Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.参与人类卵巢肿瘤的两个假定的11号染色体抑癌基因的染色体定位。
Br J Cancer. 1992 Dec;66(6):1030-6. doi: 10.1038/bjc.1992.405.
10
Whole chromosome 17 loss in ovarian cancer.
Genes Chromosomes Cancer. 1993 Nov;8(3):195-8. doi: 10.1002/gcc.2870080310.

引用本文的文献

1
Emerging roles for the GPI-anchored tumor suppressor OPCML in cancers.糖基磷脂酰肌醇锚定的肿瘤抑制因子OPCML在癌症中的新作用。
Cancer Gene Ther. 2021 Feb;28(1-2):18-26. doi: 10.1038/s41417-020-0187-6. Epub 2020 Jun 29.
2
Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.孕激素受体诱导卵巢癌细胞中 FOXO1 依赖性衰老。
Cell Cycle. 2013 May 1;12(9):1433-49. doi: 10.4161/cc.24550. Epub 2013 Apr 10.
3
Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.

本文引用的文献

1
Microsatellite instability in cancer of the proximal colon.近端结肠癌中的微卫星不稳定性
Science. 1993 May 7;260(5109):816-9. doi: 10.1126/science.8484122.
2
Clues to the pathogenesis of familial colorectal cancer.家族性结直肠癌的发病机制线索。
Science. 1993 May 7;260(5109):812-6. doi: 10.1126/science.8484121.
3
Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.人类卵巢癌中11号染色体短臂上的结构杂合性缺失。与分化程度呈正相关。
上皮性卵巢癌及低恶性潜能肿瘤中的雌激素和孕激素受体状态与预后
Gynecol Oncol. 2009 Sep;114(3):480-5. doi: 10.1016/j.ygyno.2009.05.045. Epub 2009 Jun 27.
4
Estrogen, progesterone and epithelial ovarian cancer.雌激素、孕激素与上皮性卵巢癌
Reprod Biol Endocrinol. 2003 Oct 7;1:73. doi: 10.1186/1477-7827-1-73.
5
The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.位于11号染色体11q23 - q24区域的BCSC - 1基因座是一个候选肿瘤抑制基因。
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11517-22. doi: 10.1073/pnas.1934602100. Epub 2003 Sep 22.
6
RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma.
Br J Cancer. 2003 Jul 7;89(1):146-51. doi: 10.1038/sj.bjc.6601049.
7
Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.位于11号染色体q23区域的PPP2R1B候选抑癌基因的体细胞突变在卵巢癌中并不常见。
Neoplasia. 1999 Oct;1(4):311-4. doi: 10.1038/sj.neo.7900042.
Cancer. 1993 Oct 15;72(8):2423-32. doi: 10.1002/1097-0142(19931015)72:8<2423::aid-cncr2820720821>3.0.co;2-p.
4
A microsatellite-based index map of human chromosome 11.基于微卫星的人类11号染色体索引图谱。
Hum Mol Genet. 1993 Jul;2(7):909-13. doi: 10.1093/hmg/2.7.909.
5
Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors.卵巢肿瘤中11p13威尔姆斯肿瘤抑制基因(WT1)的分析。
Cancer Invest. 1993;11(4):393-9. doi: 10.3109/07357909309018871.
6
Cytogenetic studies of epithelial ovarian carcinoma.上皮性卵巢癌的细胞遗传学研究
Cancer Genet Cytogenet. 1993 Nov;71(1):76-86. doi: 10.1016/0165-4608(93)90205-z.
7
Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer.
Int J Cancer. 1994 Apr 1;57(1):63-6. doi: 10.1002/ijc.2910570112.
8
Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.人类卵巢癌中11号染色体q臂的杂合性缺失与扩增
Br J Cancer. 1993 Feb;67(2):268-73. doi: 10.1038/bjc.1993.51.
9
Assignment of 112 microsatellite markers to 23 chromosome 11 subregions delineated by somatic hybrids: comparison with the genetic map.
Genomics. 1994 May 15;21(2):379-87. doi: 10.1006/geno.1994.1280.
10
Molecular mechanisms possibly affecting WT1 function in human ovarian tumors.可能影响WT1在人类卵巢肿瘤中功能的分子机制。
Int J Cancer. 1994 May 15;57(4):515-21. doi: 10.1002/ijc.2910570413.